[May 05, 2014] |
|
IDT Reports Q4 and Fiscal Year 2014 Financial Results
SAN JOSE, Calif. --(Business Wire)--
Integrated Device Technology, Inc. (IDT®) (NASDAQ: IDTI), the
Analog and Digital Company™ delivering essential mixed-signal
semiconductor solutions, today announced results for the fiscal fourth
quarter and fiscal year ended March 30, 2014.
"We concluded fiscal year 2014 on a high note with strong Q4 revenue,
non-GAAP operating margin and earnings per share," said Greg Waters,
president and chief executive officer. "The strength in revenues for the
fourth fiscal quarter was primarily driven by sales in our
Communications end market as the build-out of global 4G/LTE
infrastructure accelerated. Non-GAAP gross margin was slightly impacted
by inventory reserves associated with our previous fab closure
transition and product mix. However, with our continued focus on expense
control, we exceeded our guidance for non-GAAP operating margins and
non-GAAP EPS, delivering 19.5% and $0.14 per fully diluted share,
respectively."
"We have successfully transformed IDT into a company that generates
earnings power as our revenue continues to grow, all supported by a very
strong balance sheet. We are investing in high-growth markets and
believe we can grow market share in all of our target market segments
through the course of this fiscal year," concluded Mr. Waters.
Recent Business Highlights
-
Nominated for four prestigious ACE awards, presented by UBM Tech's EE
Times and EDN publications, IDT won top prize in the "Ultimate
Products" category for its third generation Universal Frequency
Translator (UFT) clocking family. The three other nominations were for
the Timing Commander™ software, an RF-PLL and DDR4 data buffer.
-
IDT announced the mass production of its JEDEC 1.0-compliant DDR4
chipset-already validated by Intel® to meet the requirements of the
future Intel Xeon™ processor E5-2600 v3 product family--for use in
RDIMMs and LRDIMMs.
-
IDT extended its leadership in the timing market with the VersaClock 5
family of programmable clock generators, the best-in-class, complete
clock tree solution for cost-sensitive, low-power consumer and
low-jitter communication timing applications.
-
IDT introduced the industry's first Ethernet and IEEE 1588 timing
devices optimized for smart grid and industrial automation
applications. The new low-jitter timing products improve the accuracy
and reliability of IEEE 1588 time transport and offer important
flexibility with an integrated Ethernet digital PLL (DPLL) and
digitally-controlled oscillator (DCO) in a single chip.
-
IDT announced a new family of ultra-compact wireless power receivers
offering a board area footprint reduction up to 70% compared to
switching regulator-based solutions. The latest Wireless Power
Consortium's (WPC) and Power Matter's Alliance (PMA)-compliant devices
expand IDT's industry-leading wireless power portfolio to address
densely populated, cost-sensitive portable applications.
-
IDT introduced the industry's first dual-mode wireless power receiver
compatible with both the WPC 1.1 standard, as well as the PMA 1.1
standard. The innovative solution enables OEMs to use a single
wireless power receiver IC to develop mobile devices fully compatible
with the latest versions of both Qi and PMA charging bases.
The following highlights the Company's financial performance on both a
GAAP and supplemental non-GAAP basis. The company is pursuing the
divestiture of its high speed data converter business and is in active
discussions with potential buyers. For financial statement purposes, the
high speed data converter business is classified as assets held for sale
and is treated as discontinued operations for all periods presented. IDT
has excluded results from the high speed data converter business from
current and historical non-GAAP results. The Company provides
supplemental information regarding its operating performance on a
non-GAAP basis that excludes certain gains, losses and charges which
occur relatively infrequently and which management considers to be
outside our core operating results. Non-GAAP results are not in
accordance with GAAP and may not be comparable to non-GAAP information
provided by other companies. Non-GAAP information should be considered a
supplement to, and not a substitute for, financial statements prepared
in accordance with GAAP. A complete reconciliation of GAAP to non-GAAP
results from continuing operations is attached to this press release.
-
Revenue from continuing operations for the fiscal fourth quarter of
2014 was $118.6 million, compared with $107.8 million reported in the
same period one year ago.
-
GAAP net income from continuing operations for the fiscal fourth
quarter of 2014 was $5.4 million, or $0.04 per diluted share, versus a
GAAP net loss from continuing operations of $5.5 million or a loss of
$0.04 per share in the same period one year ago. Fiscal fourth quarter
2014 GAAP results include a $14.5 million loss relating to
amortization and impairment of intangible assets and other
acquisition/divestiture related charges, $2.4 million in stock-based
compensation expense, $1.1 million in restructuring related charges,
and $1.3 million expense from related tax effects.
-
Non-GAAP net income for the fiscal fourth quarter of 2014 was $22.1
million or $0.14 per diluted share, compared with non-GAAP net income
of $4.9 million or $0.03 per diluted share reported in the same period
one year ago.
-
GAAP gross profit from continuing operations for the fiscal fourth
quarter of 2014 was $61.1 million, or 51.5 percent, compared with GAAP
gross profit of $59.5 million, or 55.2 percent, reported in the same
period one year ago. Non-GAAP gross profit for the fiscal fourth
quarter of 2014 was $72.5 million, or 61.1 percent, compared with
non-GAAP gross profit of $62.7 million, or 58.2 percent, reported in
the same period one year ago.
-
GAAP R&D expense for the fiscal fourth quarter of 2014 was $32.7
million, compared with GAAP R&D expense of $42.1 million reported in
the same period one year ago. Non-GAAP R&D expense for the fiscal
fourth quarter of 2014 was $28.4 million, compared with non-GAAP R&D
of $35.0 million in the same period one year ago.
-
GAAP SG&A expense for the fiscal fourth quarter of 2014 was $23.2
million, compared with GAAP SG&A expense of $27.8 million in the same
period one year ago. Non-GAAP SG&A expense for the fiscal fourth
quarter of 2014 was $20.9 million, compared with non-GAAP SG&A expense
of $22.1 million in the same period one year ago.
Webcast and Conference Call Information
Investors may listen to a live or replay webcast of the Company's
quarterly financial conference call at http://ir.idt.com/.
The live webcast will begin at 1:30 p.m. Pacific time on May 5, 2014.
The webcast replay will be available after 5 p.m. Pacific time on May 5,
2014.
Investors may also listen to the live call at 1:30 p.m. Pacific time on
May 5, 2014 by calling (877) 941-1427 or (480) 629-9664. The access code
is 4678229. The conference call replay will be available for one week
after the event at (800) 406-7325 or (303) 590-3030. The access code is
4678229.
About
IDT
Integrated Device Technology, Inc., the Analog and Digital Company™,
develops system-level solutions that optimize its customers'
applications. IDT uses its market leadership in timing, serial switching
and interfaces, and adds analog and system expertise to provide complete
application-optimized, mixed-signal solutions for the communications,
computing and consumer segments. Headquartered in San Jose, Calif., IDT
has design, manufacturing, sales facilities and distribution partners
throughout the world. IDT stock is traded on the NASDAQ Global Select
Stock Market® under the symbol "IDTI."
Additional information about IDT is accessible at www.IDT.com.
Follow IDT on Facebook,
LinkedIn,
Twitter,
and YouTube.
Forward Looking Statements
Investors are cautioned that forward-looking statements in this release,
including but not limited to statements regarding demand for Company
products, anticipated trends in Company sales, expenses and profits,
involve a number of risks and uncertainties that could cause actual
results to differ materially from current expectations. Risks include,
but are not limited to, global business and economic conditions,
fluctuations in product demand, manufacturing capacity and costs,
inventory management, competition, pricing, patent and other
intellectual property rights of third parties, timely development and
introduction of new products and manufacturing processes, dependence on
one or more customers for a significant portion of sales, successful
integration of acquired businesses and technology, availability of
capital, cash flow and other risk factors detailed in the Company's
Securities and Exchange Commission filings. The Company urges investors
to review in detail the risks and uncertainties in the Company's
Securities and Exchange Commission filings, including but not limited to
the Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
All forward-looking statements are made as of the date of this release
and the Company disclaims any duty to update such statements.
Non-GAAP Reporting
To supplement its consolidated financial results presented in accordance
with GAAP, IDT uses non-GAAP financial measures which are adjusted from
the most directly comparable GAAP financial measures to exclude certain
items, as described in detail below. Management believes that these
non-GAAP financial measures reflect an additional and useful way of
viewing aspects of the Company's operations that, when viewed in
conjunction with IDT's GAAP results, provide a more comprehensive
understanding of the various factors and trends affecting the Company's
business and operations. It should also be noted that IDT's non-GAAP
information may be different from the non-GAAP information provided by
other companies. Non-GAAP financial measures used by IDT include:
• Cost of revenues;
• Gross profit;
• Research and development expenses;
• Selling, general and administrative expenses;
• Interest income and other;
• Provision (benefit) for income taxes, continuing operations
• Operating income (loss);
• Net income (loss) from continuing operations;
• Diluted net income (loss) per share, continuing operations; and
• Weighted average shares outstanding - diluted
The Company presents non-GAAP financial measures because the investor
community uses non-GAAP results in its analysis and comparison of
historical results and projections of the Company's future operating
results. These non-GAAP results exclude acquisition related expense,
restructuring and divestiture related costs (gain), share-based
compensation expense, results from discontinued operations, stockholder
expenses and certain other expenses and benefits. Management uses these
non-GAAP measures to manage and assess the profitability of the
business. These non-GAAP results are also consistent with the way
management internally analyzes IDT's financial results.
There are limitations in using non-GAAP financial measures because they
are not prepared in accordance with GAAP and may be different from
non-GAAP financial measures used by other companies. The presentation of
non-GAAP financial information is not meant to be considered in
isolation or as a substitute for the most directly comparable GAAP
financial measures. The non-GAAP financial measures supplement, and
should be viewed in conjunction with, GAAP financial measures. Investors
should review the reconciliations of the non-GAAP financial measures to
their most directly comparable GAAP financial measures as provided in
the accompanying press release.
As presented in the "Reconciliation of GAAP to Non-GAAP" tables in the
accompanying press release, each of the non-GAAP financial measures
excludes one or more of the following items:
Acquisition related. Acquisition-related
charges are not factored into management's evaluation of potential
acquisitions or IDT's performance after completion of acquisitions,
because they are not related to the Company's core operating
performance. Adjustments of these items provide investors with a basis
to compare IDT's performance to other companies without the variability
caused by purchase accounting. Acquisition-related expenses primarily
include:
-
Amortization of acquisition related intangibles, which include
acquired intangibles such as purchased technology, patents, customer
relationships, trademarks, backlog and non-compete agreements.
-
Acquisition related costs such as legal, accounting and other
professional or consulting fees directly related to an acquisition.
-
Other acquisition related costs which consists of an accrued deferred
closing date fee associated with the acquisition of NXP's high-speed
data converter assets.
-
Fair market value adjustment to acquired inventory sold.
Restructuring related. Restructuring
charges primarily relate to changes in IDT's infrastructure in efforts
to reduce costs and expenses (gains) associated with strategic
divestitures and restructuring in force actions. Restructuring charges
(gains) are excluded from non-GAAP financial measures because they are
not considered core operating activities. Although IDT has engaged in
various restructuring activities in the past, each has been a discrete
event based on a unique set of business objectives. As such, management
believes that it is appropriate to exclude restructuring charges (gains)
from IDT's non-GAAP financial measures as it enhances the ability of
investors to compare the Company's period-over-period operating results
from continuing operations. Restructuring-related charges (gains)
primarily include:
-
Severance and retention costs directly related to a restructuring
action.
-
Facility closure costs consist of ongoing costs associated with the
exit of our leased and owned facilities.
-
Gain on divestiture consists of gains recognized upon the strategic
sale of business units.
-
Assets impairments consists of an impairment charge related to a note
receivable and subsequent recoveries.
-
Asset impairments, consists of the accelerated depreciation of certain
design tools no longer in use
Other adjustments. These items are excluded
from non-GAAP financial measures because they are not related to the
core operating activities and on-going future operating performance of
IDT. Excluding this data allows investors to better compare IDT's
period-over-period performance without such expense, which IDT believes
may be useful to the investor community. Other adjustments primarily
include:
-
Stock based compensation expense.
-
Expenses related to stockholder activities reflect advisory fees
related to inquiries of Starboard Value LP.
-
Compensation expense (benefit) - deferred compensation, consists of
gains and losses on marketable equity securities related to our
deferred compensation arrangements.
-
Loss (gain) on deferred compensation plan securities represents the
changes in the fair value of the assets in a separate trust that is
invested in corporate owned life insurance under our deferred
compensation plan.
-
Life insurance proceeds received, represents proceeds received under
corporate owned life insurance under our deferred compensation plan.
-
Tax effects of non-GAAP adjustments.
-
Diluted weighted average shares non-GAAP adjustment, for purposes of
calculating non-GAAP diluted net income per share, the GAAP diluted
weighted average shares outstanding is adjusted to exclude the
benefits of stock compensation expense attributable to future services
not yet recognized in the financial statements that are treated as
proceeds assumed to be used to repurchase shares under the GAAP
treasury method.
IDT and the IDT logo are trademarks or registered trademarks of
Integrated Device Technology, Inc. All other brands, product names and
marks are or may be trademarks or registered trademarks used to identify
products or services of their respective owners.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTEGRATED DEVICE TECHNOLOGY, INC.
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
(Unaudited)
|
(In thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Twelve Months Ended
|
|
|
Mar. 30,
|
|
Dec. 29,
|
|
Mar. 31,
|
|
|
|
Mar. 30,
|
|
Mar. 31,
|
|
|
2014
|
|
|
2013
|
|
|
2013
|
|
|
|
|
2013
|
|
2013
|
Revenues
|
|
$
|
118,640
|
|
|
$
|
124,628
|
|
|
$
|
107,779
|
|
|
|
|
$
|
484,779
|
|
|
$
|
484,452
|
|
Cost of revenues
|
|
|
57,509
|
|
|
|
49,689
|
|
|
|
48,256
|
|
|
|
|
|
211,826
|
|
|
|
214,728
|
|
Gross profit
|
|
|
61,131
|
|
|
|
74,939
|
|
|
|
59,523
|
|
|
|
|
|
272,953
|
|
|
|
269,724
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
32,656
|
|
|
|
31,063
|
|
|
|
42,096
|
|
|
|
|
|
140,595
|
|
|
|
159,471
|
|
Selling, general and administrative
|
|
|
23,213
|
|
|
|
23,687
|
|
|
|
27,784
|
|
|
|
|
|
101,039
|
|
|
|
117,648
|
|
Total operating expenses
|
|
|
55,869
|
|
|
|
54,750
|
|
|
|
69,880
|
|
|
|
|
|
241,634
|
|
|
|
277,119
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
5,262
|
|
|
|
20,189
|
|
|
|
(10,357
|
)
|
|
|
|
|
31,319
|
|
|
|
(7,395
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) from divestiture
|
|
|
(302
|
)
|
|
|
(3,415
|
)
|
|
|
7,986
|
|
|
|
|
|
78,632
|
|
|
|
7,986
|
|
Other-than-temporary impairment loss on investments
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,708
|
)
|
|
|
|
|
-
|
|
|
|
(1,708
|
)
|
Other income (expense), net
|
|
|
786
|
|
|
|
1,108
|
|
|
|
258
|
|
|
|
|
|
2,707
|
|
|
|
1,708
|
|
Income (loss) from continuing operations before income taxes
|
|
|
5,746
|
|
|
|
17,882
|
|
|
|
(3,821
|
)
|
|
|
|
|
112,658
|
|
|
|
591
|
|
Provision (benefit) for income taxes
|
|
|
320
|
|
|
|
543
|
|
|
|
1,648
|
|
|
|
|
|
981
|
|
|
|
(2,120
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) from continuing operations
|
|
|
5,426
|
|
|
|
17,339
|
|
|
|
(5,469
|
)
|
|
|
|
|
111,677
|
|
|
|
2,711
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain from divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
886
|
|
Loss from discontinued operations
|
|
|
(5,016
|
)
|
|
|
(10,123
|
)
|
|
|
(4,995
|
)
|
|
|
|
|
(22,938
|
)
|
|
|
(23,653
|
)
|
Provision (benefit) for income taxes
|
|
|
17
|
|
|
|
268
|
|
|
|
163
|
|
|
|
|
|
11
|
|
|
|
116
|
|
Net income (loss) from discontinued operations
|
|
|
(5,033
|
)
|
|
|
(10,391
|
)
|
|
|
(5,158
|
)
|
|
|
|
|
(22,949
|
)
|
|
|
(22,883
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
393
|
|
|
$
|
6,948
|
|
|
$
|
(10,627
|
)
|
|
|
|
$
|
88,728
|
|
|
$
|
(20,172
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) per share continuing operations
|
|
$
|
0.04
|
|
|
$
|
0.11
|
|
|
$
|
(0.04
|
)
|
|
|
|
$
|
0.75
|
|
|
$
|
0.02
|
|
Basic net income (loss) per share discontinued operations
|
|
|
(0.04
|
)
|
|
|
(0.06
|
)
|
|
|
(0.03
|
)
|
|
|
|
|
(0.16
|
)
|
|
|
(0.16
|
)
|
Basic net income (loss) per share
|
|
$
|
-
|
|
|
$
|
0.05
|
|
|
$
|
(0.07
|
)
|
|
|
|
$
|
0.59
|
|
|
$
|
(0.14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share continuing operations
|
|
$
|
0.04
|
|
|
$
|
0.11
|
|
|
$
|
(0.04
|
)
|
|
|
|
$
|
0.73
|
|
|
$
|
0.02
|
|
Diluted net income (loss) per share discontinued operations
|
|
|
(0.04
|
)
|
|
|
(0.07
|
)
|
|
|
(0.03
|
)
|
|
|
|
|
(0.15
|
)
|
|
|
(0.16
|
)
|
Diluted net income (loss) per share
|
|
$
|
-
|
|
|
$
|
0.04
|
|
|
$
|
(0.07
|
)
|
|
|
|
$
|
0.58
|
|
|
$
|
(0.14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
150,033
|
|
|
|
151,018
|
|
|
|
145,626
|
|
|
|
|
|
149,480
|
|
|
|
144,014
|
|
Diluted
|
|
|
154,390
|
|
|
|
155,035
|
|
|
|
145,626
|
|
|
|
|
|
153,369
|
|
|
|
145,678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTEGRATED DEVICE TECHNOLOGY, INC.
|
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (a)
|
(Unaudited)
|
(In thousands, except per share data)
|
|
|
Three Months Ended
|
|
|
|
Twelve Months Ended
|
|
|
Mar. 30,
|
|
Dec. 29,
|
|
Mar. 31,
|
|
|
|
Mar. 30,
|
|
Mar. 31,
|
|
|
2014
|
|
2013
|
|
2013
|
|
|
|
2013
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) from continuing operations
|
|
$
|
5,426
|
|
|
$
|
17,339
|
|
|
$
|
(5,469
|
)
|
|
|
|
$
|
111,677
|
|
|
$
|
2,711
|
|
GAAP diluted net income (loss) per share continuing operations
|
|
$
|
0.04
|
|
|
$
|
0.11
|
|
|
$
|
(0.04
|
)
|
|
|
|
$
|
0.73
|
|
|
$
|
0.02
|
|
Acquisition related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition related intangibles
|
|
|
11,999
|
|
|
|
3,322
|
|
|
|
4,097
|
|
|
|
|
|
21,964
|
|
|
|
16,339
|
|
Impairment of acquired in-process R&D
|
|
|
2,433
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
2,433
|
|
|
|
-
|
|
Acquisition related legal and consulting fees
|
|
|
73
|
|
|
|
21
|
|
|
|
1,009
|
|
|
|
|
|
802
|
|
|
|
11,238
|
|
Fair market value adjustment to acquired inventory sold
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
358
|
|
Restructuring related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance and retention costs
|
|
|
383
|
|
|
|
400
|
|
|
|
1,662
|
|
|
|
|
|
6,456
|
|
|
|
5,522
|
|
Facility closure costs
|
|
|
107
|
|
|
|
6
|
|
|
|
2
|
|
|
|
|
|
134
|
|
|
|
62
|
|
Gain on divestiture
|
|
|
302
|
|
|
|
3,415
|
|
|
|
(7,986
|
)
|
|
|
|
|
(78,632
|
)
|
|
|
(7,986
|
)
|
Assets impairment and other
|
|
|
334
|
|
|
|
(265
|
)
|
|
|
5,687
|
|
|
|
|
|
4,113
|
|
|
|
6,096
|
|
Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary impairment loss on investments
|
|
|
-
|
|
|
|
-
|
|
|
|
1,708
|
|
|
|
|
|
-
|
|
|
|
1,708
|
|
Stock-based compensation expense
|
|
|
2,368
|
|
|
|
3,169
|
|
|
|
3,813
|
|
|
|
|
|
12,677
|
|
|
|
13,054
|
|
Expenses related to stockholder activities
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,000
|
)
|
|
|
|
|
-
|
|
|
|
1,614
|
|
Compensation expense (benefit)-deferred compensation plan
|
|
|
185
|
|
|
|
557
|
|
|
|
704
|
|
|
|
|
|
1,265
|
|
|
|
1,135
|
|
Loss (gain) on deferred compensation plan securities
|
|
|
(171
|
)
|
|
|
(627
|
)
|
|
|
(696
|
)
|
|
|
|
|
(1,316
|
)
|
|
|
(941
|
)
|
Life insurance proceeds received
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
(2,313
|
)
|
Tax effects of Non-GAAP adjustments
|
|
|
(1,331
|
)
|
|
|
(1,402
|
)
|
|
|
1,381
|
|
|
|
|
|
(4,389
|
)
|
|
|
(7,910
|
)
|
Non-GAAP net income from continuing operations
|
|
$
|
22,108
|
|
|
$
|
25,935
|
|
|
$
|
4,912
|
|
|
|
|
$
|
77,184
|
|
|
$
|
40,687
|
|
GAAP weighted average shares - diluted
|
|
|
154,390
|
|
|
|
155,035
|
|
|
|
145,626
|
|
|
|
|
|
153,369
|
|
|
|
145,678
|
|
Non-GAAP adjustment
|
|
|
1,492
|
|
|
|
2,099
|
|
|
|
5,026
|
|
|
|
|
|
1,981
|
|
|
|
1,934
|
|
Non-GAAP weighted average shares - diluted
|
|
|
155,882
|
|
|
|
157,134
|
|
|
|
150,652
|
|
|
|
|
|
155,350
|
|
|
|
147,612
|
|
Non-GAAP diluted net income per share continuing operations
|
|
$
|
0.14
|
|
|
$
|
0.17
|
|
|
$
|
0.03
|
|
|
|
|
$
|
0.50
|
|
|
$
|
0.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP gross profit
|
|
|
61,131
|
|
|
|
74,939
|
|
|
|
59,523
|
|
|
|
|
|
272,953
|
|
|
|
269,724
|
|
Acquisition and divestiture related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition related intangibles
|
|
|
11,016
|
|
|
|
2,435
|
|
|
|
2,740
|
|
|
|
|
|
18,321
|
|
|
|
12,413
|
|
Fair market value adjustment to acquired inventory sold
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
358
|
|
Restructuring related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance and retention costs
|
|
|
117
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
204
|
|
|
|
607
|
|
Facility closure costs
|
|
|
-
|
|
|
|
2
|
|
|
|
(9
|
)
|
|
|
|
|
8
|
|
|
|
4
|
|
Assets impairment and other
|
|
|
105
|
|
|
|
(142
|
)
|
|
|
(37
|
)
|
|
|
|
|
(111
|
)
|
|
|
372
|
|
Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation expense (benefit)-deferred compensation plan
|
|
|
55
|
|
|
|
172
|
|
|
|
217
|
|
|
|
|
|
388
|
|
|
|
324
|
|
Stock-based compensation expense
|
|
|
61
|
|
|
|
403
|
|
|
|
263
|
|
|
|
|
|
1,189
|
|
|
|
1,113
|
|
Non-GAAP gross profit
|
|
|
72,485
|
|
|
|
77,809
|
|
|
|
62,697
|
|
|
|
|
|
292,952
|
|
|
|
284,915
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP R&D expenses:
|
|
|
32,656
|
|
|
|
31,063
|
|
|
|
42,096
|
|
|
|
|
|
140,595
|
|
|
|
159,471
|
|
Acquisition and divestiture related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of acquired in-process R&D
|
|
|
(2,433
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
(2,433
|
)
|
|
|
-
|
|
Restructuring related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance and retention costs
|
|
|
(264
|
)
|
|
|
(86
|
)
|
|
|
(1,560
|
)
|
|
|
|
|
(4,193
|
)
|
|
|
(3,882
|
)
|
Facility closure costs
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(6
|
)
|
|
|
|
|
(9
|
)
|
|
|
(43
|
)
|
Assets impairment and other
|
|
|
(63
|
)
|
|
|
123
|
|
|
|
(3,203
|
)
|
|
|
|
|
(4,058
|
)
|
|
|
(3,203
|
)
|
Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation expense (benefit)-deferred compensation plan
|
|
|
(90
|
)
|
|
|
(289
|
)
|
|
|
(365
|
)
|
|
|
|
|
(650
|
)
|
|
|
(626
|
)
|
Stock-based compensation expense
|
|
|
(1,389
|
)
|
|
|
(1,514
|
)
|
|
|
(2,001
|
)
|
|
|
|
|
(5,601
|
)
|
|
|
(6,691
|
)
|
Non-GAAP R&D expenses
|
|
|
28,417
|
|
|
|
29,295
|
|
|
|
34,961
|
|
|
|
|
|
123,651
|
|
|
|
145,026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP SG&A expenses:
|
|
|
23,213
|
|
|
|
23,687
|
|
|
|
27,784
|
|
|
|
|
|
101,039
|
|
|
|
117,648
|
|
Acquisition and divestiture related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition related intangibles
|
|
|
(983
|
)
|
|
|
(887
|
)
|
|
|
(1,357
|
)
|
|
|
|
|
(3,643
|
)
|
|
|
(3,926
|
)
|
Acquisition related legal and consulting fees
|
|
|
(73
|
)
|
|
|
(21
|
)
|
|
|
(1,009
|
)
|
|
|
|
|
(802
|
)
|
|
|
(11,238
|
)
|
Restructuring related:
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance and retention costs
|
|
|
(2
|
)
|
|
|
(314
|
)
|
|
|
(102
|
)
|
|
|
|
|
(2,059
|
)
|
|
|
(1,033
|
)
|
Facility closure costs
|
|
|
(107
|
)
|
|
|
(2
|
)
|
|
|
(5
|
)
|
|
|
|
|
(117
|
)
|
|
|
(15
|
)
|
Assets impairment and other
|
|
|
(166
|
)
|
|
|
-
|
|
|
|
(2,521
|
)
|
|
|
|
|
(166
|
)
|
|
|
(2,521
|
)
|
Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation expense (benefit)-deferred compensation plan
|
|
|
(40
|
)
|
|
|
(96
|
)
|
|
|
(122
|
)
|
|
|
|
|
(227
|
)
|
|
|
(185
|
)
|
Stock-based compensation expense
|
|
|
(918
|
)
|
|
|
(1,252
|
)
|
|
|
(1,549
|
)
|
|
|
|
|
(5,887
|
)
|
|
|
(5,250
|
)
|
Expenses related to stockholder activities
|
|
|
-
|
|
|
|
-
|
|
|
|
1,000
|
|
|
|
|
|
-
|
|
|
|
(1,614
|
)
|
Non-GAAP SG&A expenses
|
|
|
20,924
|
|
|
|
21,115
|
|
|
|
22,119
|
|
|
|
|
|
88,138
|
|
|
|
91,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP interest income and other, net
|
|
|
786
|
|
|
|
1,108
|
|
|
|
258
|
|
|
|
|
|
2,707
|
|
|
|
1,708
|
|
Loss (gain) on deferred compensation plan securities
|
|
|
(171
|
)
|
|
|
(627
|
)
|
|
|
(696
|
)
|
|
|
|
|
(1,316
|
)
|
|
|
(941
|
)
|
Life insurance proceeds received
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
(2,313
|
)
|
Non-GAAP interest income and other, net
|
|
|
615
|
|
|
|
481
|
|
|
|
(438
|
)
|
|
|
|
|
1,391
|
|
|
|
(1,546
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP provision (benefit) for income taxes continuing operations
|
|
|
320
|
|
|
|
543
|
|
|
|
1,648
|
|
|
|
|
|
981
|
|
|
|
(2,120
|
)
|
Tax effects of Non-GAAP adjustments (7)
|
|
|
1,331
|
|
|
|
1,402
|
|
|
|
(1,381
|
)
|
|
|
|
|
4,389
|
|
|
|
7,910
|
|
Non-GAAP provision for income taxes continuing operations
|
|
|
1,651
|
|
|
|
1,945
|
|
|
|
267
|
|
|
|
|
|
5,370
|
|
|
|
5,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Refer to the accompanying "Notes to Non-GAAP Financial Measures"
for a detailed discussion of management's use of non-GAAP financial
measures.
|
|
|
|
|
|
|
INTEGRATED DEVICE TECHNOLOGY, INC.
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
(Unaudited)
|
|
|
|
|
|
|
|
Mar. 30,
|
|
March 31,
|
(In thousands)
|
|
2014
|
|
2013
|
|
|
|
|
|
ASSETS
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
91,211
|
|
$
|
130,837
|
Short-term investments
|
|
|
362,604
|
|
|
166,333
|
Accounts receivable, net
|
|
|
68,904
|
|
|
62,083
|
Inventories
|
|
|
49,622
|
|
|
56,555
|
Prepaid and other current assets
|
|
|
13,034
|
|
|
24,697
|
Total current assets
|
|
|
585,375
|
|
|
440,505
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
69,827
|
|
|
74,988
|
Goodwill
|
|
|
135,644
|
|
|
144,924
|
Acquisition-related intangibles
|
|
|
18,741
|
|
|
48,602
|
Other assets
|
|
|
21,373
|
|
|
19,560
|
TOTAL ASSETS
|
|
$
|
830,960
|
|
$
|
728,579
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
25,442
|
|
$
|
23,244
|
Accrued compensation and related expenses
|
|
|
24,343
|
|
|
21,090
|
Deferred income on shipments to distributors
|
|
|
14,006
|
|
|
14,539
|
Deferred taxes liabilities
|
|
|
1,346
|
|
|
1,000
|
Other accrued liabilities
|
|
|
11,160
|
|
|
14,652
|
Total current liabilities
|
|
|
76,297
|
|
|
74,525
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
1,494
|
|
|
1,552
|
Long term income taxes payable
|
|
|
266
|
|
|
454
|
Other long term obligations
|
|
|
18,683
|
|
|
22,022
|
Total liabilities
|
|
|
96,740
|
|
|
98,553
|
|
|
|
|
|
Stockholders' equity
|
|
|
734,220
|
|
|
630,026
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
830,960
|
|
$
|
728,579
|
[ Back To TMCnet.com's Homepage ]
|